Healthy
Showing NaN - NaN of 83
Healthy Trial in Brussels (Sisunatovir, Rabeprazole)
Not yet recruiting
- Healthy
-
Brussels, Bruxelles-capitale, Région DE, BelgiumPfizer Clinical Research Unit - Brussels
Oct 24, 2023
Healthy Trial in Brussels (Sinsunatovir, Bitrex)
Recruiting
- Healthy
- Sinsunatovir
- Bitrex
-
Brussels, Bruxelles-capitale, Région DE, BelgiumPfizer Clinical Research Unit - Brussels
Aug 15, 2023
Healthy, Men, Adults Trial in Brussels (Cycling exercise, Cycling control)
Recruiting
- Healthy
- +2 more
- Cycling exercise
- Cycling control
-
Brussels, BelgiumInstitute of Neuroscience, UCLouvain
Jul 17, 2023
Healthy Trial in Brussels (Newly Developed Ankle Brace)
Not yet recruiting
- Healthy
- Newly Developed Ankle Brace
-
Brussels, BelgiumVrije Universiteit Brussel
Apr 20, 2023
Healthy, Primary Immune Thrombocytopenia, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Trial in Worldwide
Recruiting
- Healthy
- +2 more
- PF-06755347 intravenous healthy participant
- +4 more
-
New Haven, Connecticut
- +5 more
Dec 29, 2022
Healthy Trial in Brussels (Placebo, PF-07612577, PF-06264006)
Recruiting
- Healthy
- Placebo
- +2 more
-
Brussels, Bruxelles-capitale, Région DE, BelgiumBrussels Clinical Research Unit
Nov 22, 2022
Healthy Trial in Brussels (Sayana Press)
Recruiting
- Healthy
- Sayana Press
-
Brussels, Bruxelles-capitale, Région DE, BelgiumBrussels Clinical Research Unit
May 23, 2022
Parkinson Disease, Parkinson, Healthy Trial in Brussels (1x1 Low Intensity Transcranial Direct Current Stimulation (tDCS))
Active, not recruiting
- Parkinson Disease
- +2 more
- 1x1 Low Intensity Transcranial Direct Current Stimulation (tDCS)
-
Brussels, Brussel, BelgiumVrije Universiteit Brussel
Apr 29, 2022
Healthy Trial in Brussels (PF-07059013, Placebo)
Terminated
- Healthy
- PF-07059013
- Placebo
-
Brussels, Bruxelles-capitale, Région DE, BelgiumBrussels Clinical Research Unit
Jan 13, 2022
Healthy Trial in Brussels (Recifercept, Placebo)
Completed
- Healthy
- Recifercept
- Placebo
-
Brussels, Bruxelles-capitale, Région DE, BelgiumBrussels Clinical Research Unit
Jan 5, 2022
Healthy Trial in Brussels (1x1 Low Intensity Transcranial Direct Current Stimulation (tDCS), 4x1 Multichannel Stimulation
Completed
- Healthy
- 1x1 Low Intensity Transcranial Direct Current Stimulation (tDCS)
- 4x1 Multichannel Stimulation Adapter for High Definition Transcranial Direct Current Stimulation (HD tDCS)
-
Brussels, Brussel, BelgiumVrije Universiteit Brussel
Nov 18, 2021
Healthy Trial in Brussels (SIMEOX)
Unknown status
- Healthy
- SIMEOX
-
Brussels, BelgiumWilliam Poncin
Nov 2, 2020
Healthy, Pulmonary Disease, Chronic Obstructive Trial in Brussels (SIMEOX, PEP, Spontaneous Exhalation)
Unknown status
- Healthy
- Pulmonary Disease, Chronic Obstructive
- SIMEOX
- +2 more
-
Brussels, Brussels Capital, BelgiumCliniques universitaires Saint-Luc
Nov 1, 2020
Uric Acid Metabolism, Endothelial Function and Oxidative Stress
Completed
- Healthy
- Diet Modification
- Endothelial function and inflammation
-
Brussels, Belgique, BelgiumErasme Hospital
Jun 29, 2020
Healthy Trial in Brussels (PF-07081532, Placebo)
Completed
- Healthy
- PF-07081532
- Placebo
-
Brussels, Bruxelles-capitale, Région DE, BelgiumBrussels Clinical Research Unit
Mar 23, 2020
Healthy Trial in Brussels (PF-04965842, Dabigatran)
Completed
- Healthy
-
Brussels, BelgiumPfizer Clinical Research Unit
Feb 26, 2020
Healthy Trial in Brussels (Metformin, PF-04965842)
Completed
- Healthy
-
Brussels, BelgiumPfizer Clinical Research Unit
Jan 22, 2020
Mental Fatigue, Healthy Trial in Brussels (Mental fatigue, Control)
Completed
- Mental Fatigue
- Healthy
- Mental fatigue
- Control
-
Brussels, (non-US), BelgiumHuman Physiology and Sports Physiotherapy Research Group
Oct 4, 2019
Healthy, Creatine Supplementation Trial in Brussels (Creatine, Calcium lactate)
Completed
- Healthy
- Creatine Supplementation
- Creatine
- Calcium lactate
-
Brussels, BelgiumHuman Physiology and Sports Physiotherapy Research Group
Oct 4, 2019
Healthy Trial in Brussels (PF-04965842, Rosuvastatin)
Completed
- Healthy
-
Brussels, BelgiumPfizer Clinical Research Unit
May 2, 2019